oa Hematopoietic Stem Cell Transplantation

References

1. Spangrude GJ. Biological and clinical aspects of hemopoietic stem cells. Ann Rev Med. 1994; 45::93–104.
   [Google الباحث العلمي]
2. Thomas ED, Lochte HL Jr, Cannon JH, Sahler OD, Ferrebee JW. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest. 1959; 38::1709–1716.
   [Google الباحث العلمي]
3. Thomas ED, Buckner CD, Banaji M, et al., One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977; 49::511–533.
   [Google الباحث العلمي]
4. Gratwohl A, Hermans J, Baldomero H, et al., Indications for hemopoietic precursor cell transplants in Europe. J Hematol. 1996; 92::35–43.
   [Google الباحث العلمي]
5. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1998; 21:1:1–7.
   [Google الباحث العلمي]
6. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al., Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood. 1998; 91::756–763.
   [Google الباحث العلمي]
7. Thomas DD. Bone marrow transplantation. A review. Semin Hematol. 1999; 36:Suppl 7:95–103.
   [Google الباحث العلمي]
8. Goldschmidt H, Hegenbart U, Haas R, Hunstein W. Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7g/m2) and granulocyte colonystimulating factor in patients with multiple myeloma. Bone Marrow Transplant. 1996; 17::691–697.
   [Google الباحث العلمي]
9. Comenzo RL, Malachowski ME, Miller KB, et al., Engraftment with peripheral blood stem cells collected by large volume leucopheresis for patients with lymphoma. Transfusion. 1992; 32::729–731.
   [Google الباحث العلمي]
10. Rubinstein R, Dobrila L, Rosenfield RE, et al., Processing and cryopreservativation of placenta/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995; 92::10119–10122.
    [Google الباحث العلمي]
11. Gluckman E, Rocha V, Chastang C. Cord blood stem cell transplantation. Bailliere's Clin Hematol. 1999; 12::279–292.
    [Google الباحث العلمي]
12. Gluckman E. Current status of UCB/HSCT. Exp Hematol. 2000; 28::1197–1205.
    [Google الباحث العلمي]
13. Barker JN, Weisdorf DJ, DeFor TE, et al., Transplantation of partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005; 105::1343–1347.
    [Google الباحث العلمي]
14. Lemoli RM, Curti A, Tura S. Negative Selection of autologous peripheral blood stem cells. Baillier's Clin Hematol. 1999; 12::57–69.
    [Google الباحث العلمي]
15. Appelbaum FR. HSCT as immunotherapy. Nature. 2001; 411::385–389.
    [Google الباحث العلمي]
16. Kottaridis PD, Milligan DW, Chopra R. In vivo CAMPATH-1H prevents graft versus host disease following nonmyeloablative stem cell transplantation. Blood. 2000; 96::2419–2425.
    [Google الباحث العلمي]
17. Lee JH, Choi SJ, Kim S, et al., GVHD specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic HSCT. Br J Hematol. 2003; 122::637–644.
    [Google الباحث العلمي]
18. Miller KB, Schenkein DP, Comenzo RL, et al., Adjusted dose continuous infusion cyclosporine A to prevent GVHD following allogeneic bone marrow transplantation. Ann Hematol. 1994; 68::15–20.
    [Google الباحث العلمي]
19. Goulmy E. Human Minor histocompatibility antigens; new concepts for marrow transplantation and adoptive immunotherapy. Imm Rec. 1997; 157::125–140.
    [Google الباحث العلمي]
20. Sasazuki T, Juji T, Morishiema Y, et al., Effect of matching of class 1 HLA alleles on Clinical outcome after transplantation of haemopoietic stem cells for an unrelated donor. N Engl J Med. 1998; 1339::1177–1185.
    [Google الباحث العلمي]
21. Hows J, Bradley B. Transplantation for patients without HLA identical siblings. In: Brenner MKHojfbrand AV, eds. Recent advances in haematology. Vol 8. London: Churchill Livingstone 1996;:191–212.
    [Google الباحث العلمي]
22. Khouri IF, Kealing M. Transplant-lite: Induction of graftversus-malignancy using fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies. J CO. 1998; 16::2817–2824.
    [Google الباحث العلمي]
23. MacKinnon S. Who may benefit from donor leucocyte infusions after allogeneic SCT? Br J Hematol. 2000; 110::12–17.
    [Google الباحث العلمي]
24. Cullis JO, Jiang YZ, Schworer AP, et al., Donor leucocytes infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantations. Blood. 1992; 79::1379–1381.
    [Google الباحث العلمي]
25. Hebart H, Einfele H. Diagnosis and treatments of cytomegalovirus infection. Current Opin. Hematol. 1998; 5::483–487.
    [Google الباحث العلمي]
26. De Marie S. New developments in the diagnosis and management of invasive fungal infections. Hematologica. 2000; 85::88–93.
    [Google الباحث العلمي]
27. Johnson PWM, Simnett SJ, Sweetenham JW, Morgan GJ, Stewart LA. Bone marrow and peripheral blood SCT for malignancy. Health Techn Assess. 1998; 2::1–187.
    [Google الباحث العلمي]